Asset Details
Do you wish to reserve the book?
Influenza vaccine production for Brazil: A classic example of successful North–South bilateral technology transfer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Influenza vaccine production for Brazil: A classic example of successful North–South bilateral technology transfer
Do you wish to request the book?
Influenza vaccine production for Brazil: A classic example of successful North–South bilateral technology transfer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Influenza vaccine production for Brazil: A classic example of successful North–South bilateral technology transfer
2011
Overview
Technology transfer is a promising approach to increase vaccine production at an affordable price in developing countries. In the case of influenza, it is imperative that developing countries acquire the technology to produce pandemic vaccines through the transfer of know-how, as this will be the only way for the majority of these countries to face the huge demand for vaccine created by influenza pandemics. Access to domestically produced influenza vaccine in such health crises is thus an important national defence strategy. However, technology transfer is not a simple undertaking. It requires a committed provider who is willing to transfer a complete production process, and not just the formulation and fill-finish parts of the process. It requires a recipient with established experience in vaccine production for human use and the ability to conduct research into new developments. In addition, the country of the recipient should preferably have sufficient financial resources to support the undertaking, and an internal market for the new vaccine. Technology transfer should create a solid partnership that results in the joint development of new competency, improvements to the product, and to further innovation.
The Instituto Butantan–sanofi pasteur partnership can be seen as a model for successful technology transfer and has led to the technological independence of the Instituto Butantan in the use a strategic public health tool.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Antigens
/ Brazil
/ Eggs
/ Humans
/ Influenza vaccine production
/ Influenza Vaccines - supply & distribution
/ Influenza, Human - epidemiology
/ Influenza, Human - prevention & control
/ Joints
/ LDCs
/ pandemic
/ Pandemics - prevention & control
/ prices
/ Technology, Pharmaceutical - methods
/ Technology, Pharmaceutical - organization & administration
/ Vaccines
